Log in to save to my catalogue

Cancer treatment monitoring using cell-free DNA fragmentomes

Cancer treatment monitoring using cell-free DNA fragmentomes

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8005c4ee68144cd383ff212f1b67d00a

Cancer treatment monitoring using cell-free DNA fragmentomes

About this item

Full title

Cancer treatment monitoring using cell-free DNA fragmentomes

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2024-10, Vol.15 (1), p.8801-12, Article 8801

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Circulating cell-free DNA (cfDNA) assays for monitoring individuals with cancer typically rely on prior identification of tumor-specific mutations. Here, we develop a tumor-independent and mutation-independent approach (DELFI-tumor fraction, DELFI-TF) using low-coverage whole genome sequencing to determine the cfDNA tumor fraction and validate the...

Alternative Titles

Full title

Cancer treatment monitoring using cell-free DNA fragmentomes

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_8005c4ee68144cd383ff212f1b67d00a

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8005c4ee68144cd383ff212f1b67d00a

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-024-53017-7

How to access this item